Evidence map›Paper›PMID 30250860›Full record

ArticleAnnals of clinical and translational neurology2018

Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross-sectional diffusion tensor imaging study.

Lize C Jiskoot, Martina Bocchetta, Jennifer M Nicholas, David M Cash, David Thomas, Marc Modat, Sebastien Ourselin, Serge A R B Rombouts, Elise G P Dopper, Lieke H Meeter and 21 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Composite grey matter fingerprints for genetic frontotemporal dementia.Journal of neurology, neurosurgery, and psychiatry · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Neuroimaging and biomarker evidence of neurodegeneration in asthma.The Journal of allergy and clinical immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 18 institutions in 8 countries.

Lize C JiskootDepartment of Neurology Erasmus Medical Center Rotterdam the Netherlands.
Martina BocchettaDementia Research Center University College London London United Kingdom.
Jennifer M NicholasDementia Research Center University College London London United Kingdom.ORCID 0000-0001-6023-0391
David M CashDementia Research Center University College London London United Kingdom.
David ThomasDementia Research Center University College London London United Kingdom.
Marc ModatDementia Research Center University College London London United Kingdom.
Sebastien OurselinDementia Research Center University College London London United Kingdom.
Serge A R B RomboutsDepartment of Radiology Leiden University Medical Center Leiden the Netherlands.
Elise G P DopperDepartment of Neurology Erasmus Medical Center Rotterdam the Netherlands.
Lieke H MeeterDepartment of Neurology Erasmus Medical Center Rotterdam the Netherlands.
Jessica L PanmanDepartment of Neurology Erasmus Medical Center Rotterdam the Netherlands.
Rick van MinkelenDepartment of Clinical Genetics Erasmus Medical Center Rotterdam the Netherlands.
Emma L van der EndeDepartment of Neurology Erasmus Medical Center Rotterdam the Netherlands.
Laura Donker KaatDepartment of Neurology Erasmus Medical Center Rotterdam the Netherlands.
Yolande A L PijnenburgDepartment of Neurology Alzheimer Center Neuroscience Campus Amsterdam Amsterdam the Netherlands.
Barbara BorroniNeurology Unit Department of Clinical and Experimental Sciences University of Brescia Brescia Italy.
Daniela GalimbertiDepartment of Pathophysiology and Transplantation Dino Ferrari Center University of Milan Fondazione Ca` Granda IRCCS Ospedale Maggiore Policlinico Milan Italy.
Mario MasellisLC Campbell Cognitive Neurology Research Unit Sunnybrook Research Institute Toronto Ontario Canada.
Maria Carmela TartagliaTanz Centre for Research in Neurodegenerative Diseases University of Toronto Toronto Ontario Canada.
James RoweDepartment of Clinical Neurosciences University of Cambridge Cambridge United Kingdom.
Caroline GraffDepartment of Geriatric Medicine Karolinska University Hospital-Huddinge Stockholm Sweden.
Fabrizio TagliaviniFondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologica Carlo Besta Milan Italy.
Giovanni B FrisoniIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Centro San Giovanni di Dio Fatebenefratelli Brescia Italy.
Robert LaforceClinique Interdisciplinaire de Mémoire Département des Sciences Neurologiques Université Laval Québec Quebec Canada.
Elizabeth FingerDepartment of Clinical Neurological Sciences University of Western Ontario Toronto Ontario Canada.
Alexandre de MendonçaFaculty of Medicine University of Lisbon Lisbon Portugal.
Sandro SorbiDepartment of NEUROFARBA University of Florence Florence Italy.
Genetic Frontotemporal dementia Initiative (GENFI)
Janne M PapmaDepartment of Neurology Erasmus Medical Center Rotterdam the Netherlands.
John C van SwietenDepartment of Neurology Erasmus Medical Center Rotterdam the Netherlands.
Jonathan D RohrerDementia Research Center University College London London United Kingdom.
Erasmus MC · NLUK Dementia Research Institute · GBLeiden University Medical Center · NLAmsterdam Neuroscience · NLFondazione IRCCS Istituto Neurologico Carlo Besta · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITKarolinska University Hospital · SELeiden University · NLLondon School of Hygiene & Tropical Medicine · GBSunnybrook Health Science Centre · CAUniversité Laval · CAUniversity of Brescia · ITUniversity of Cambridge · GBUniversity of Geneva · CHUniversity of Lisbon · PTUniversity of Milan · ITUniversity of Toronto · CAWestern University · CA

Funding

Medical Research Council MC_U105597119Medical Research Council MC_UU_00005/12Medical Research Council MC_UU_00024/1Medical Research Council MR/J009482/1Medical Research Council MR/M008525/1Medical Research Council MR/M023664/1Wellcome Trust 103838
6 · The paper itself

Abstract

Objective: We aimed to investigate mutation-specific white matter (WM) integrity changes in presymptomatic and symptomatic mutation carriers of the Methods: One hundred and forty mutation carriers (54 Results: Diffusion changes in Interpretation: This study demonstrates the presence of early and widespread WM integrity loss in presymptomatic FTD, and suggests a clear genotypic "fingerprint." Our findings corroborate the notion of FTD as a network-based disease, where changes in connectivity are some of the earliest detectable features, and identify diffusion tensor imaging as a potential neuroimaging biomarker for disease-tracking and -staging in presymptomatic to early-stage familial FTD.

Identifiers

PMID30250860
PMCPMC6144447
OpenAlexW2847223726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.